Molecular biological approaches to neurological disorders including knockout and transgenic mouse models

Neuropathology

Volumn 22, Issue 4, 2002, Pages 337-349

  Shibata, Noriyuki ^a   Oda, Hideaki ^a   Hirano, Asao ^b   Kato, Yoichiro ^a   Kawaguchi, Motoko ^a   Dal Canto, Mauro C ^c   Uchida, Koji ^d   Sawada, Tatsuo ^a   Kobayashi, Makio ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d NAGOYA UNIVERSITY   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Giant cell glioblastoma; Knockout mice; Molecular biology; Transgenic mice

Indexed keywords

GLUTAMATE TRANSPORTER; MESSENGER RNA; PROTEIN P53; SUPEROXIDE DISMUTASE;

AGAR GEL ELECTROPHORESIS; AMYOTROPHIC LATERAL SCLEROSIS; ANTIBODY DETECTION; ANTIBODY TITER; CONFERENCE PAPER; DNA PROBE; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE MUTATION; GIANT CELL; GIANT CELL GLIOBLASTOMA; GLIOBLASTOMA; HUMAN; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; INTERMETHOD COMPARISON; KNOCKOUT MOUSE; MASS SPECTROMETRY; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TRANSGENIC MOUSE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BLOTTING, SOUTHERN; CENTRAL NERVOUS SYSTEM DISEASES; DISEASE MODELS, ANIMAL; GRANULOMA, GIANT CELL; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MOLECULAR BIOLOGY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0036968628     PISSN: 09196544     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1789.2002.00449.x     Document Type: Article

References (39)

1. Ohgaki H, Peraud A, Nakazato Y, Watanabe K, von Deimling A. Giant cell glioblastoma. In: Kleihues, P, Cavenee, W, eds. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Nervous System, 1st edn. Lyon: International Agency for Research on Cancer, 2000; 40-41.
2. Shibata N, Hirano A, Yamamoto T, Kato Y, Kobayashi M. Superoxide dismutase-1 mutation-related neurotoxicity in familial amyotrophic lateral sclerosis. ALS 2000; 1: 143-161.
3. Brown Jr. RH, Meininger V, Swash M. Amyotrophic Lateral Sclerosis. London: Martin Dunitz 2000.
4. Meyer-Puttlitz B, Hayashi Y, Waha A et al. Molecular genetic analysis of giant cell glioblastomas. Am J Pathol 1997; 151: 853-857.
5. Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 1992; 70: 937-948.
6. Shaw P, Bovey R, Tardy S, Sahli R, Scordat B, Costa J. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA 1992; 89: 4495-4499.
7. Oda H, Zhang S, Tsurutani N et al. Loss of p53 is an early event in induction of brain tumors in mice by transplacental carcinogen exposure. Cancer Res 1997; 57: 646-650.
8. Shibata N. Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Neuropathology 2001; 21: 82-92.
9. Tsukada T, Tomooka Y, Takai S et al. Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene 1993; 8: 3313-3322.
10. Ausubel FM, Brent R, Kingston RE et al. Short Protocols in Molecular Biology, 3rd edn. New York: John Wiley & Sons 1995.
11. Mullis KB, Faloona FA. Specific synthesis of DNA in vitro polymerase-catalyzed chain reaction. Meth Enzymol 1987; 155: 335-350.
12. Kusaka H, Hirano A. Cytopathology of the motor neuron. In: Younger, DS, ed. Motor Disorders. Philadelphia: Lippincott Williams & Wilkins 1999, 93-101.
13. Shibata N, Kobayashi M. Amyotrophic lateral sclerosis. Implication for oxidative stress. Pathol Clin Med 2001; 19: 744-751 (in Japanese).
14. Rosen DR, Siddique T, Patterson D et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59-62.
15. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 503-517.
16. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989; 5: 874-879.
17. Carothers AM, Urlaub G, Mucha J, Grunberger D, Chasin LA. Point mutation analysis in a mammalian gene. Rapid preparation of total RNA PCR amplification of cDNA, and Taq sequencing by a novel method. Biotechniques 1989; 7: 494-499.
18. Shibata N, Hirano A, Kobayashi M et al. Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J Neuropathol Exp Neurol 1996; 55: 481-490.
19. Shibata N, Hirano A, Kobayashi M et al. Presence of Cu/Zn superoxide dismutase (SOD) immunoreactivity in neuronal hyaline inclusions in spinal cords from mice carrying a transgene for Gly93Ala mutant human Cu/Zn SOD. Acta Neuropathol 1998; 95: 136-142.
20. Johnston JA, Dalton MJ, Gurney ME, Kopito RR. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 2000; 97: 12571-12576.
21. Bruijn LI, Becher MW, Lee MK et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 1997; 18: 327-338.
22. Howland DS, Liu J, She Y et al. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci USA 2002; 99: 1604-1609.
23. Durham HD, Roy J, Dong L et al. Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS. J Neuropathol Exp Neurol 1997; 56: 523-530.
24. Gurney ME, Pu H, Chiu AY et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994; 264: 1772-1775.
25. Rothstein DR, Kammen MV, Levey AI, Martin LJ, Kuncl RW. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995; 38: 73-84.
26. Bendotti C, Tortarolo M, Suchak SK et al. Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels. J Neurochem 2001; 79: 737-746.
27. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning, 2nd edn. New York: Cold Spring Harbor Laboratory 1989.
28. Larrick JW, Siebert PD. Reverse Transcriptase PCR, 1st edn. London: Ellis Horwood 1995.
29. Denijin M, De Weger RA, Berends MJH et al. Detection of calcitonin-encoding mRNA by radioactive and non-radioactive in situ hybridization: improved colorimetric detection and cellular localization of mRNA in thyroid sections. J Histochem Cytochem 1990; 38: 351-358.
30. Towbin H, Staehelin T, Gordon J. Electrophoresis transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-4354.
31. Pedersen WA, Fu W, Keller JN et al. Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann Neurol 1998; 44: 819-824.
32. Shibata N, Nagai R, Miyata S et al. Non oxidative protein glycation is implicated in familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Acta Neuropathol 2000; 100: 275-284.
33. Shibata N, Nagai R, Uchida K et al. Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients. Brain Res 2001; 917: 97-104.
34. Shibata N, Hirano A, Hedley-Whyte ET et al. Selective formation of certain advanced glycation end products in spinal cord astrocytes of humans and mice with superoxide dismutase-1 mutation. Acta Neuropathol 2002; 104: 171-178.
35. Almer G, Guégan C, Teismann P et al. Increased expression of the proinflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann Neurol 2001; 49: 176-185.
36. Drachman DB, Rothstein JD. Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis. Ann Neurol 2000; 48: 792-795.
37. Kumagai T, Kawamoto Y, Nakamura Y et al. 4-Hydroxy-2-nonenal, the end product of lipid peroxidation, is a specific inducer of cyclooxygenase-2 gene expression. Biochem Biophys Res Commun 2000; 273: 437-441.
38. 2 metabolite generated during inflammatory processes. J Biol Chem 2002; 277: 10459-10466.
39. 2: the endogeneous electrophile that induces neuronal apoptosis. Proc Natl Acad Sci USA 2002; 99: 7367-7372.